The full Clinical Report is published in the Int. J. Pharm. & Pharm. Sci. Vol.3. Suppl 3. 2011, p80-83.
Authors: Dr Ng Guat Hua, MD; Dr Lee Yu Ming MD; and Dr Jonathan Obaje PhD, C.Sci, MRSC.
Objective: To evaluate the potential efficacy, safety and patient satisfaction following osteoarthritis (OA) treatment with a new Micellar transdermal formulation of glucosamine.
Conclusion: Urah Micellar Transdermal Glucosamine Cream significantly alleviated pain in arthritic joints when applied over four weeks, suggesting an improvement in quality of life, and possible route-efficacy relationship in glucosamine therapy.
To read the full published article, click here
Click here to Check the Best Product for your Pain Condition
Click here to Check How to Use Urah Products
Click here to Check the Quality of your Glucosamine Product before use
Subscribe to our newsletter and stay up to date with the latest news and health care tips!
2024 © URAH Transdermal Pte Ltd. ALL Rights Reserved. Urah Privacy Policy | Terms of Service | Return Policy
Disclaimer: All contents on this website are provided for general information only, and should not be treated as a substitute for the medical advice of your Physician or any other health care professional. Urah is not responsible or liable for any diagnosis made by any user based on the content of this website. Always consult your own Physician if you're in any way concerned about your health.
